LYEL Lyell Immunopharma, Inc.

Healthcare

$16.37-6.24%ClosedMarket Cap: $382.0M

As of 2026-05-26

Analyst Consensus

Consensus

Buy

Target (Consensus)

$46.00

Target (Median)

$45.00

Target Range

$44.00 - $49.00

Upside from current price: 181.0%

2 Strong Buy3 Buy0 Hold0 Sell1 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-05-07	Needham	maintain	Buy	Buy
2025-12-09	HC Wainwright & Co.	upgrade	Buy	Neutral
2025-11-24	HC Wainwright & Co.	maintain	Neutral	Neutral
2025-06-24	HC Wainwright & Co.	maintain	Neutral	Neutral

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-8.46	$1.9M	4
Sun Dec 31	$-7.07	$56.7M	3
Mon Dec 31	$-5.12	$190.2M	1
Tue Dec 31	$-4.07	$280.0M	1